In subsequent research, a series of potential anticancer drugs were screened to investigate their potential therapeutic role by targeting RAB5B.The expression level of RAB5B in tumor is used to guide drug selection, and the drug sensitivity analysis of RAB5B shows that methotrexate has great potential to develop new molecular targeted therapy. Here, RAB5B is linked to neoplasm.